MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
MBX Biosciences (Nasdaq: MBX) announced that CEO Kent Hawryluk and CMO Sam Azoulay, M.D., will present at the 37th Annual Piper Sandler Healthcare Conference on December 2, 2025.
Presentation format: fireside chat and 1x1 meetings; time: 4:00 p.m.–4:25 p.m. ET; location: New York, NY. The presentation will be webcast live and a replay will be posted approximately two hours after the event and archived on the company website for about 90 days.
Investors can access the live webcast and replay via the events section of the MBX Biosciences investor website.
MBX Biosciences (Nasdaq: MBX) ha annunciato che il CEO Kent Hawryluk e il CMO Sam Azoulay, M.D., parteciperanno alla 37ª conferenza annuale Piper Sandler Healthcare il 2 dicembre 2025.
Formato presentazione: chiacchierata informale e incontri 1x1; orario: 16:00–16:25 ora dell'Est; sede: New York, NY. La presentazione sarà trasmessa in diretta e una replica sarà disponibile circa due ore dopo l'evento e archiviata sul sito dell'azienda per circa 90 giorni.
Gli investitori possono accedere alla trasmissione in diretta e alla replica tramite la sezione eventi del sito investitori di MBX Biosciences.
MBX Biosciences (Nasdaq: MBX) anunció que el CEO Kent Hawryluk y el CMO Sam Azoulay, M.D., participarán en la 37.ª Conferencia Anual de Piper Sandler Healthcare el 2 de diciembre de 2025.
Formato de la presentación: charla junto a la chimenea y reuniones 1x1; hora: 4:00 p. m.–4:25 p. m. ET; ubicación: New York, NY. La presentación se transmitirá en vivo y habrá una repetición aproximadamente dos horas después del evento, y se archivará en el sitio web de la empresa durante unos 90 días.
Los inversores pueden acceder a la transmisión en vivo y a la repetición a través de la sección eventos del sitio web de inversores de MBX Biosciences.
MBX Biosciences (나스닥: MBX)가 CEO Kent Hawryluk 및 CMO Sam Azoulay, M.D.가 제37회 Piper Sandler Healthcare 연례 컨퍼런스에 2025년 12월 2일 발표한다고 발표했습니다.
발표 형식: 세담 대화 및 1x1 미팅; 시간: 동부 표준시 16:00–16:25; 장소: 뉴욕, NY. 발표는 라이브로 방송되며 행사 약 2시간 후에 다시 보기가 게시되고 약 90일간 회사 웹사이트에 보관됩니다.
투자자들은 MBX Biosciences 투자자 웹사이트의 이벤트 섹션을 통해 라이브 방송과 리플레이에 접속할 수 있습니다.
MBX Biosciences (Nasdaq : MBX) a annoncé que le PDG Kent Hawryluk et le CMO Sam Azoulay, M.D., participeront à la 37e conférence annuelle Piper Sandler Healthcare le 2 décembre 2025.
Format de la présentation : conversation au coin du feu et réunions en tête-à-tête; heure : 16h00–16h25, heure de l'Est; lieu : New York, NY. La présentation sera diffusée en direct et une répétition sera publiée environ deux heures après l'événement et archivée sur le site Web de l'entreprise pendant environ 90 jours.
Les investisseurs peuvent accéder à la diffusion en direct et à la répétition via la section événements du site Investisseurs de MBX Biosciences.
MBX Biosciences (Nasdaq: MBX) kündigte an, dass CEO Kent Hawryluk und CMO Sam Azoulay, M.D., am 37. Piper Sandler Healthcare Conference am 2. Dezember 2025 teilnehmen werden.
Präsentationsformat: Kamin-Gespräch und 1-zu-1 Meetings; Zeit: 16:00–16:25 Uhr EST; Ort: New York, NY. Die Präsentation wird live gestreamt und eine Aufzeichnung wird etwa zwei Stunden nach der Veranstaltung verfügbar sein und ca. 90 Tage auf der Unternehmenswebsite archiviert werden.
Investoren können über den Veranstaltungen-Bereich der MBX Biosciences Investorenseite auf den Live-Stream und die Aufzeichnung zugreifen.
أعلنت MBX Biosciences (ناسداك: MBX) أن الرئيس التنفيذي كينت هارويلوك وCMO سام أزولاي، د.م.س، سيشاركان في المؤتمر الصحي السنوي الـ37 لشركة Piper Sandler في 2 ديسمبر 2025.
تنسيق العرض: حديث بجلسة أمام المدفأة واجتماعات فردية 1×1؛ الوقت: 4:00–4:25 مساءً بتوقيت الساحل الشرقي؛ المكان: نيويورك، نيويورك. سيتم بث العرض مباشرة وسيتم رفع نسخة إعادة عرض بعد نحو ساعتين من الحدث وتخزينه في موقع الشركة الإلكتروني لمدة حوالي 90 يوماً.
يمكن للمستثمرين الوصول إلى البث المباشر وإعادة العرض من خلال قسم الأحداث في موقع MBX Biosciences للمستثمرين.
- None.
- None.
CARMEL, Ind., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present and participate in the 37th Annual Piper Sandler Healthcare Conference being held on December 2-4.
37th Annual Piper Sandler Healthcare Conference
Date: Tuesday, December 2, 2025
Format: Fireside chat and 1x1 meetings
Time: 4:00 p.m. – 4:25 p.m. ET
Location: New York, NY
The live webcast can be accessed in the events section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events. Access to the webcast replay will be available approximately two hours after the completion of the events and will be archived on the Company’s website for approximately 90 days.
About MBX Biosciences
MBX Biosciences is a biopharmaceutical company focused on the discovery and development of novel precision peptide therapies based on its proprietary PEP™ platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism (HP) in Phase 2 development; imapextide (1416) for the treatment of post-bariatric hypoglycemia (PBH) in Phase 2 development; and an obesity portfolio that includes MBX 4291 in Phase 1 development, as well as multiple discovery and pre-clinical obesity candidates. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at https://mbxbio.com/ and follow it on LinkedIn.
Media Contact:
Cassidy McClain
Inizio Evoke Comms
cassidy.mcclain@inizioevoke.com
(619) 694-6291
Investor Contact:
Jim DeNike
MBX Biosciences
jdenike@mbxbio.com
FAQ
When will MBX Biosciences (MBX) present at the Piper Sandler Healthcare Conference?
Who from MBX Biosciences will present at the December 2, 2025 MBX (MBX) session?
How can investors watch MBX Biosciences (MBX) presentation on December 2, 2025?
When will the replay of the MBX Biosciences (MBX) Piper Sandler presentation be available?
What is the format and location of MBX Biosciences (MBX) presentation at the conference?
Where on the MBX Biosciences website can I find the live webcast and replay for the December 2, 2025 event?
